Research / UNH
UnitedHealth Strong Buy
Cumulative score 9.5 · the model has rated UNH Strong Buy since Jul 17, 2026 · 21 active of 135 total events · Healthcare
Automated research experiment, not investment advice. An AI model scores public information; a formula flips ratings. It can be wrong, late, or stale. I may hold positions. Do your own research.
The model rates UnitedHealth Strong Buy at the score ceiling, driven by converging positive signals across earnings, analyst actions, and legal risk clearance. UNH lifted its 2026 outlook on Medicare and Optum improvement, Baird upgraded the stock outright, and an external audit found 97 percent of HouseCalls diagnoses supported by patient records, materially clearing a high-profile Medicare fraud allegation. The primary risk the model is watching is Medicaid margin pressure, highlighted by Elevance's Q2 results showing margin collapse despite a headline beat. A significant upward revision to UNH's own medical loss ratio guidance or a new federal investigation into billing practices would be the most likely events to pull the rating lower.
Written Jul 17, 2026, when the rating was Strong Buy. Rewritten automatically each time the rating flips.
Score history
Daily cumulative score. The model enters Buy above +5.0, Strong Buy above +7.5, and Sell below -5.0; each tier exits at a looser threshold so ratings don't flap.
Rating changes
Triggered by: UnitedHealth Q2 Earnings Call Focuses on Reset and Durable Growth · Baird Upgrades UnitedHealth Group (UNH) · Elevance Beat Earnings Estimates, but the Stock Falls on Medicaid Spending Worries
Triggered by: External audit of UnitedHealth senior home visits finds most diagnoses supported by medical data · Can UNH's Lifestyle Spending Account Redefine Employee Benefits? · EXCLUSIVE: Berkshire’s Alphabet, UnitedHealth Buys Show CEO Greg Abel Is Expanding the Playbook, Expert Says
Event history
Every informational event the model has scored for UNH, newest first, with its reasoning and what each event still contributes to the score today.
JP Morgan Maintains Overweight on UnitedHealth Group, Raises Price Target to $516
Unscored after 3 attempts.
UnitedHealth: The Cure For The AI Blues
Unscored after 3 attempts.
UnitedHealth Stock: Is It Headed for $500?
Unscored after 3 attempts.
Diamondback Energy shares are trading higher after Raymond James maintained a Strong Buy rating on the stock and raised its price target from $210 to $240.
Unscored after 3 attempts.
10 Health Care Stocks With Whale Alerts In Today’s Session
Unscored after 3 attempts.
All You Need to Know About UnitedHealth (UNH) Rating Upgrade to Strong Buy
Unscored after 3 attempts.
Which dow jones stocks are moving on Tuesday?
Unscored after 3 attempts.
Dow Rises 500 Points. It’s Not a Broad Rally.
Unscored after 3 attempts.
Stay informed with the top movers within the dow jones index on Tuesday.
Unscored after 3 attempts.
How Much UNH Are You Really Betting On?
Unscored after 3 attempts.
What Kept Coming Up When Analysts Grilled UNH
Unscored after 3 attempts.
The Hidden Engine Behind Elevance Health Stock's Next Climb
Unscored after 3 attempts.
UNH Stock Tracks Hot Monthly Streak: Wall Street Cheers ‘Impressive’ Q2 And Sees Over 20% More Room To Run
Unscored after 3 attempts.
Apple, UnitedHealth Group And A Basic Material Stock: CNBC’s ‘Final Trades’
Unscored after 3 attempts.
Barclays Maintains Overweight on UnitedHealth Group, Raises Price Target to $441
Unscored after 3 attempts.
CVS Health Update: The C- Student Now Pulling Down A B+
Unscored after 3 attempts.
Tempus to buy cancer test-maker Personalis for $1.5B
Unscored after 3 attempts.
The Real Risk Inside UnitedHealth Stock
Unscored after 3 attempts.
UnitedHealth Group (UNH) is a Great Momentum Stock: Should You Buy?
Unscored after 3 attempts.
Uncover the latest developments among dow jones stocks in today's session.
Unscored after 3 attempts.
2.6 Million People Lost Their Medicare Advantage Plan This Year: Here's How To Avoid Being Caught Off Guard For 2027
Unscored after 3 attempts.
UnitedHealth CFO sends stark warning after earnings
Earnings beat and guidance raise occurred July 16; this July 19 recap of the CFO's call commentary is a second story on already-priced information.
UnitedHealth Group (UNH) Stock Still Looks Cheap Following Raised 2026 Outlook
Second story on UNH's raised outlook; valuation opinion adds nothing new to the already-known beat-and-raise.
This Week's Market Wrap: AI Shakeup, Earnings, And Renewed Oil Shock
General weekly market wrap; UNH not specifically analyzed.
Benzinga Bulls and Bears: PayPal, UnitedHealth, Netflix — And Stocks End Wild Week
Weekly Benzinga roundup mentioning UNH among several stocks; no new information.
UnitedHealth Just Told Us The Economy Isn't Breaking․ Here's The Proof
Secondary analysis confirming UNH Q2 beat, raised EPS guidance, and Optum margin expansion; primary earnings event likely already captured.
What's A Strong Quarter Worth When Elevance Health Is Ditching Its Own Markets?
Article covers Elevance Health's strategic retreat from markets; not UNH-specific news.
What A Patient Holder Is Really Paying For CVS Health Stock
Article is about CVS Health valuation; no relevance to UNH.
UnitedHealth Lost Nearly 1 Million Medicare Members. Here's Why Investors Aren't Worried
Specific disclosure of 965,000 lost Medicare Advantage members is a notable negative detail from Q2 earnings, though the article notes investor reaction was muted.
Stock Market News for July 17, 2026
General market recap for July 17; no UNH-specific content.
Oppenheimer Maintains Outperform on UnitedHealth Group, Raises Price Target to $500
Oppenheimer raises PT from $420 to $500, maintains Outperform; meaningful PT jump but no rating change.
Baird Upgrades UnitedHealth Group (UNH)
Baird upgrade of UNH is a rating change (not just PT), which carries more informational weight than routine PT adjustments.
Keybanc Maintains Overweight on UnitedHealth Group, Raises Price Target to $500
Keybanc raises PT from $475 to $500, maintains Overweight; routine post-earnings PT housekeeping.
Morgan Stanley Maintains Overweight on UnitedHealth Group, Raises Price Target to $529
Morgan Stanley raises PT from $468 to $529, maintains Overweight; PT increase reflects post-earnings reassessment.
UnitedHealth Q2 Earnings Call Focuses on Reset and Durable Growth
UNH lifted 2026 outlook on Medicare and Optum improvement, offsetting commercial cost pressure; positive guidance revision.
UnitedHealth Poised for Further Growth Despite Employer Commercial Pressure, RBC Says
RBC positive on UNH Medicare Advantage outlook; constructive view but no rating change or material new thesis.
The First Oral Cholesterol Pill Is Here. Which of These 5 Stocks Benefits Most?
FDA approval of first oral PCSK9 inhibitor could modestly pressure UNH pharmacy benefit costs, but impact is indirect and uncertain.
Top dow jones movers in Friday's session
Midday Dow mover summary; duplicate market recap, no new information.
These dow jones stocks are moving in today's session
Intraday Dow mover summary; market noise with no new UNH-specific content.
Stocks making big moves this week: HCA Healthcare, UnitedHealth, CrowdStrike, RXO, and Enovis
Weekly movers recap; no new UNH-specific information beyond what other events already capture.
Jim Cramer Says the Market Is “Dead Wrong” About These 5 Oversold Stocks
Cramer opinion piece on oversold stocks; no primary-source information, pure punditry.
8-K filed (items 2.02,9.01)
8-K items 2.02/9.01 is the formal earnings release wrapper; content already captured in earnings call coverage.
Insurance stocks fall after Elevance Health results show margin pressure
Fifth story on ELV Health Benefits operating profit collapse; same underlying fact already scored.
Why Elevance Earnings Gave Health Insurance Stocks A Cold; UNH Up Next
Fourth story on ELV read-across to managed care; same underlying fact already scored.
Ash Adds Health Care Industry Veteran Jon Stout To Board Of Directors, Names Health Tech Finance Leader Matt Benton CFO
Ash company leadership announcement; not UNH.
Is It Worth Investing in UnitedHealth (UNH) Based on Wall Street's Bullish Views?
Generic ABR opinion piece; no new facts about UNH.
Health insurance stocks slide after Elevance highlights margin pressures (ELV)
Third story on ELV margin pressure / managed-care sector selloff; same underlying fact already scored.
Stock Market Today: Dow Rises On Surprise Inflation Data; ASML Jumps On Earnings Report (Live Coverage)
Market summary article; UNH referenced in passing only.
Netflix's Q3 Earnings Report Could Lead to $21.5 Billion Swing in Market Value
Earnings preview mentioning UNH alongside unrelated names; no UNH-specific information.
Will UnitedHealth (UNH) Beat Estimates Again in Its Next Earnings Report?
Generic earnings-surprise probability piece; no new facts about UNH.
Stay informed with the top movers within the dow jones index on Wednesday.
Generic Dow Jones movers; no UNH-specific content.
ELV Beats Q2 Earnings Estimates on Higher CarelonRx Product Revenues
Second story on ELV Q2 results; same underlying fact already scored.
Elevance Beat Earnings Estimates, but the Stock Falls on Medicaid Spending Worries
ELV Q2 revealed Medicaid margin collapse despite headline beat; direct negative read-through to UNH ahead of its own earnings report.
What's going on in today's session: dow jones movers
Generic Dow Jones movers roundup; no UNH-specific content.
US Equity Futures Drop Pre-Bell as Iran Says Strait of Hormuz Closed Once Again, Oil Prices Jump
Same Hormuz/futures macro story as 88c32d09; second story on same fact scores 0.
5 Things to Know Before the Stock Market Opens on Monday
Generic pre-market news digest; no UNH-specific content discernible from summary.
Beat the Market Like Zacks: Micron, UnitedHealth, J. M. Smucker in Focus
Zacks promotional content mentioning UNH among portfolio winners; no new company-specific information.
Update: US Equity Futures Drop Pre-Bell as Iran Says Strait of Hormuz Closed Once Again, Oil Prices Jump
Broad macro/Hormuz futures drop; no UNH-specific exposure.
UnitedHealth (UNH) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Pre-earnings analyst consensus summary for Q2; no estimates beyond what is already expected.
Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?
Article is about Humana's Medicare Advantage targets; sector context but no direct UNH news.
Discover which dow jones stocks are making waves on Monday.
Generic Dow Jones movers summary; no UNH-specific content.
The Premium On CVS Stock Vs What Its Peers Deliver
Article is primarily about CVS; UNH referenced as a peer comparator only.
Is UNH Stock Worth Buying Ahead of Q2 Earnings? Key Estimates to Watch
Pre-earnings opinion piece restating known membership pressure and cost-management narrative; no new data.
Equities Fall Intraday, Oil Soars as Trump Reinstates Iranian Shipping Blockade in Hormuz
Broad equity/oil macro story; no UNH-specific information.
Uncover the latest developments among dow jones stocks in today's session.
Generic Dow Jones movers roundup; no UNH-specific content.
Update: Nasdaq Snaps 3-Day Winning Streak as Oil Jumps Amid US-Iran Tensions
Broad market recap; no UNH-specific content.
Dow Jones Futures Loom Amid New U.S.-Iran Attacks; Nvidia, Micron, Sandisk Near Buy Points
Generic market futures article; UNH not mentioned substantively, no company-specific information.
Inflation, Bank of America, Wells Fargo, Goldman, ASML, J&J, and More to Watch This Week
Weekly earnings preview article; UNH not specifically discussed, no new UNH-specific information.
Dow Jones Futures: Watch Nvidia, Micron, Sandisk, Robinhood As Market Sets Up; Big Earnings Due
Duplicate market futures article; UNH not specifically discussed.
Dow Jones Futures: Market Ready To Go? Nvidia, Micron, Sandisk Near Buy Points With Big Earnings Due
Broad market futures recap; UNH not specifically discussed.
UnitedHealth Group (UNH) Stock Slides as Market Rises: Facts to Know Before You Trade
Price-action recap noting a 1.64% decline; no new fundamental catalyst identified in the summary.
Q2 Earnings Season Arrives: Can Results Match Upbeat Expectations?
Generic earnings-season preview; UNH is mentioned among many companies with no new specific information.
Pharmacy Benefit Manager Suit Shows Trump Admin's Keenness For Deals
Trump DOJ signaling willingness to settle with insurers on PBM antitrust suits is mildly positive for UNH's legal overhang.
Is UnitedHealth Group (UNH) Fully Valued On Raised Guidance Ahead Of Q2?
Analysis of already-disclosed guidance raise; second story on a known fact, not a new announcement.
The Main Reason Behind Buying UnitedHealth Before July 16
Pre-earnings bullish opinion piece; no new data beyond existing consensus and stock momentum.
UNH Showered Owners With Cash. The Stock Did Not Cooperate
Retrospective on UNH cash returns vs stock price; no new fundamental information.
EXCLUSIVE: Berkshire’s Alphabet, UnitedHealth Buys Show CEO Greg Abel Is Expanding the Playbook, Expert Says
Analyst commentary that Berkshire under Abel has been buying UNH; secondary-source confirmation of institutional accumulation, rumor-cap applies without direct SEC filing cited.
U.S. Futures Drift as Investors Await Earnings Season and Inflation Data: Dow Jones, S&P, Nasdaq
Generic market futures note; no UNH-specific content.
Only 1 Major S&P 500 Sector Is Really Struggling Today
Commentary on intraday sector performance; no new fundamental UNH news.
Can UNH's Lifestyle Spending Account Redefine Employee Benefits?
UNH launches Lifestyle Spending Account product via UHC Store; minor product initiative, not revenue-moving.
Is ELV's Capital Allocation Strategy Creating Long-Term Value?
Article is about Elevance Health (ELV), not UnitedHealth.
Exploring the top movers within the dow jones index during today's session.
Duplicate intraday Dow movers note; no new UNH information.
Top dow jones movers in Friday's session
Intraday movers recap; no fundamental UNH news.
Dow Jones Futures: Big Earnings Due As Market Sets Up; Nvidia, Micron, Sandisk, Robinhood, SpaceX In Focus
Broad Dow Jones futures overview; UNH mentioned only tangentially.
UNH's $1.5B AI Push: Can It Deliver More Than Cost Savings?
UNH's $1.5B AI investment for 2026 is a meaningful strategy signal, though likely partially known.
Exploring the top movers within the dow jones index during today's session.
Generic Dow Jones mid-session summary; no UNH-specific information.
Stay informed with the top movers within the dow jones index on Wednesday.
Generic Dow Jones market summary; no UNH-specific information.
Don't Buy UnitedHealth Group (UNH) Stock Before Reading This
Opinion piece questioning UNH as investment; no new factual disclosure.
Reported Earlier, 'Obamacare Insurers Seek Big Rate Hikes, Again' - WSJ Exclusive
Second story on same ACA premium hike fact already scored above; scores 0 per repeat rule.
Obamacare Premiums Could Jump 14% in 2027 As Insurers Warn Rising Medical Costs are Driving Rates Higher
ACA insurers seeking 14% premium hikes signals elevated medical costs trend, a headwind for UNH medical loss ratio.
Stryker: Medtech On Sale, Benefiting From Industry Growth
Article is about Stryker (SYK), not UnitedHealth.
External audit of UnitedHealth senior home visits finds most diagnoses supported by medical data
External audit finds 97% of HouseCalls diagnoses supported by patient records, materially clearing a high-profile Medicare fraud allegation against UNH.
Dow Jones Stocks Could Be the Perfect Portfolio for 2026 Now That Google’s in the Mix. Here’s 3 Ways to Profit.
General article on Dow Jones composition change; no UNH-specific information.
What's going on in today's session: dow jones movers
General Dow Jones market recap; no UNH-specific content.
This Stock Stumbled Last Year. Now It's the First Half's Best Performing Mega-Cap Healthcare Stock. Is It Too Late to Buy?
Recovery commentary piece; no new facts, known narrative.
UnitedHealth Group (UNH) Opens Shield Blood Test Coverage For Adults 45 And Older
UNH first major insurer to cover Guardant Shield blood test; noteworthy coverage decision but immaterial to earnings at UNH's scale.
What's going on in today's session: dow jones movers
Generic Dow Jones movers recap; no UNH-specific news.
1 Mooning Stock with Exciting Potential and 2 Facing Challenges
Generic 52-week-high market fluff with no UNH-specific content.
CVS Health: The Surprising Healthcare Outlier
CVS beat-and-raise article filed under UNH ticker; contains no new information about UnitedHealth itself.
3 Stocks to Buy and Hold: The Long-Term Play for Your Portfolio
Generic stock buy-and-hold listicle; no new UNH-specific information.
Soft Landing Myth: How This Week's Data Exposed The Hidden Recession
Macro soft landing/recession commentary; no UNH-specific content.
Can Centene's Fraud Prevention Strategy Support Margin Recovery?
Centene fraud prevention strategy piece; UNH not the subject.
What CVS Health Stock Was Telling You About Its Three-Dollar Earnings Prize
CVS/Aetna turnaround analysis; UNH not the subject.
3 Healthcare ETFs to Own in a Choppy Stock Market
Healthcare ETF listicle; UNH referenced as a sector holding, no company-specific news.
UnitedHealth Bets on Profitability Over Growth: Will It Pay Off?
Editorial analysis of UNH's known profitability-over-growth strategy; no new disclosure.
Stock Market Today: Dow Up, AI Stock Tests Entry; TeraWulf Cedes Key Level Despite Anthropic Deal (Live Coverage)
Broad market day recap; UNH not featured as a primary subject.
Explore the top gainers and losers within the dow jones index in today's session.
Generic Dow movers summary; no UNH-specific content.
UnitedHealth Group (UNH) Stock Declines While Market Improves: Some Information for Investors
Price movement recap with no new information.
Guardant Health stock surges on colon cancer blood test news
Bernstein price-target raise on Guardant Health (GH), not UNH; only tangentially related via coverage decision already scored elsewhere.
CVS Health vs. UnitedHealth: Comparing Revenue Trends for These Healthcare Companies
Retrospective revenue-trend comparison using already-reported results; no new information.
UnitedHealth: Patience Could Be Rewarded
Valuation opinion piece calling UNH a buy; no new factual content per rubric.
Dear UnitedHealth Stock Fans, Mark Your Calendars for July 16
Calendar reminder for July 16 earnings date; no new information about results or guidance.
Jim Cramer Says He Bets “The Gains in CVS Will Be Long-Lasting”
Jim Cramer commentary on CVS; no content specific to UNH.
Members of Congress Are Loading Up on Johnson & Johnson and UnitedHealth. Here's Why Retail Investors Should Pay Attention.
Soft congressional-trading signal with no hard information about UNH fundamentals or insider disclosures.
UnitedHealth (UNH) Stock Looks Reasonable Even After A 42% Gain
Post-hoc valuation analysis of the 42% run; no new facts, mixed opinion on metrics.
The Unpopular Move That Telegraphed the Elevance Health Stock Surge
Article is about Elevance Health turnaround, not UNH.
UnitedHealth Is Spending $3 Billion on AI and Getting $2 Back for Every $1. Why That Changes the Bull Case for This Blue Chip Stock.
Specific 2:1 AI ROI claim ($3B spend) is a notable bull-case datapoint if sourced from company, but article is aggregator-level and detail is unverified; minor positive capped by source uncertainty.
Guardant’s Shield colon cancer blood test snags UnitedHealth coverage
Second story (July 2) on the Shield blood-test coverage decision first announced July 1; scores 0 per repeat-story rule.
VTV’s Next 12 Months Hinge on One Fed Inflation Signal: Here’s What to Watch
VTV ETF analysis that mentions UNH only as a driver of the ETF's healthcare weighting; no UNH-specific news.
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
Zacks attention/popularity article; no new factual content about UNH.
UnitedHealth Group: The Turnaround Continues Into The Q2 Report
Single analyst raises PT to ~$460 and reiterates buy with improved earnings guidance narrative; routine positive nudge.
Can Centene's Integrated Healthcare Model Support Earnings Growth?
Centene (CNC) analysis; not about UNH.
KKM's Jeff Kilburg explains the healthcare trade in the second half of 2026
Generic healthcare sector H2 commentary; no UNH-specific facts.
Stay informed with the top movers within the dow jones index on Thursday.
Midday Dow movers chatter; no UNH-specific content.
Cigna Brings AI to Specialty Pharmacy With Pharmacy Forward
Cigna/Evernorth AI pharmacy launch; not about UNH.
Q1 Earnings Highs And Lows: UnitedHealth (NYSE:UNH) Vs The Rest Of The Health Insurance Providers Stocks
Retrospective Q1 earnings comparison across health insurers using already-public results; no new information.
Which dow jones stocks are moving on Thursday?
Generic Dow movers roundup; no UNH-specific content.
Court dismisses PBMs’ lawsuit against FTC following insulin settlements
Optum Rx (UNH subsidiary) settling FTC insulin-pricing accusations; removes litigation tail risk but confirms regulatory finding and implies settlement cost, net minor negative.
10 Health Care Stocks With Whale Alerts In Today’s Session
Generic options whale-alert roundup for healthcare sector; no UNH-specific signal.
GH Stock At Over 5-Year Highs – What’s The UnitedHealth Connection?
Second story on the same Shield coverage decision already announced July 1; scores 0 per repeat-story rule.
UnitedHealth Group Now Covers Guardant Health’s Shield Blood Test for Colorectal Cancer Screening
First major commercial insurer to cover Shield colorectal cancer blood test; concrete coverage expansion showing market leadership, though financial impact is modest at UNH's scale.
Which dow jones stocks are moving on Wednesday?
Generic Dow movers article; no UNH-specific content.
Meta's new cloud business will be instantly profitable, says Jim Cramer
Cramer commentary on Meta; no UNH content.
Which dow jones stocks are moving on Tuesday?
Generic Dow movers article; no UNH-specific content.
These Are The Best-Performing Dow Stocks Of Q2 And First Half Of 2026
Q2/H1 Dow performance roundup; no UNH-specific content.
News data via Finnhub. Filings via SEC EDGAR. Scores are model states, not recommendations.